Observational Prospective Study.at the End of the Study the Patients Will be Classified According to PH,Serum Bicarbonate and Serum Sodium Into 6 Groups and Statistical Analysis Will be Performed Using Spss
NCT ID: NCT05082064
Last Updated: 2023-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
121 participants
OBSERVATIONAL
2021-10-08
2023-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .
NCT03084185
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study
NCT05220891
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414
Acute-On-Chronic Liver Failure In Cirrhotic Patients
NCT04790435
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
NCT05249374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MELD score group A
MELD score :group A\<25
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
MELD group B
Group B\>25
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
MELD-PACO2 Group C
Group C\<25
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
MELD -PACO2 Group D
Group D\>25
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
MELD-BICARBONATE score Group E
Group E\<23
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
MELD-BICARBONATE Group F
Group F\>23
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
arterial blood gases and serum electrolytes
arterial bloog gases parameters serum potassium serum sodium serum calcium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing and agree to be included in the study
Exclusion Criteria
* cirrhotic patients whom -younger than 18 years old
* have diabetic ketoacidosis
* with acute coronary syndrome
* with fulminant liver failure
* with heart failure
* with organ transplantation
* when arterial blood gases not be available
* patient refusal
* patient with HCC
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heba Allah Fadel Abdel Rahman
doctor,principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heba allah Fadel, Doctor
Role: PRINCIPAL_INVESTIGATOR
Clinical trial organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heba Allah fadel abd elrahman
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Scheiner B, Lindner G, Reiberger T, Schneeweiss B, Trauner M, Zauner C, Funk GC. Acid-base disorders in liver disease. J Hepatol. 2017 Nov;67(5):1062-1073. doi: 10.1016/j.jhep.2017.06.023. Epub 2017 Jul 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
liver cirrhosis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.